What is the long-term trend for ResMed's accrued progress collections and price adjustments?

Over 4 years (2021 to 2025), ResMed's accrued progress collections and price adjustments has grown at a 14.4% compound annual growth rate (CAGR), from $91.5M to $156.8M.

ResMed RMD Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

InogenINGN

——

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's accrued progress collections and price adjustments?: ResMed (RMD) reported accrued progress collections and price adjustments of $163.15M in Q1 2026.
How has ResMed's accrued progress collections and price adjustments changed year-over-year?: ResMed's accrued progress collections and price adjustments increased by 8.0% year-over-year, from $151.09M to $163.15M.
What is the long-term trend for ResMed's accrued progress collections and price adjustments?: Over 4 years (2021 to 2025), ResMed's accrued progress collections and price adjustments has grown at a 14.4% compound annual growth rate (CAGR), from $91.5M to $156.8M.